Videos

Steinert Honored for His Career of Innovation

By Mario Admin | May 30, 2016

In a packed ballroom at the Intercontinental Hotel, OIS attendees recognized the achievements of one of ophthalmology’s physician-innovators. Roger F. Steinert, MD, was honored as…

Read More

AcuFocus Outlines Kamra Launch

By Mario Admin | May 30, 2016

The KAMRA small-aperture corneal inlay from AcuFocus was approved by the FDA in April 2015 for the treatment of presbyopia, and the company began a…

Read More

Ocular Therapeutix Waiting for Word from FDA

By Mario Admin | May 27, 2016

Ocular Therapeutix expects to hear from the FDA on its PDUFA date of July 24, 2016, on its new drug application for DEXTENZA, its sustained-release…

Read More

Heidelberg Makes Move into Cataract-Refractive Field

By Mario Admin | May 27, 2016

Heidelberg Engineering, which has more than 10,000 optical coherence tomography (OCT) units in place worldwide, is looking to help drive the premium channel by entering…

Read More

ForSight Reports on Phase II Bimatoprost Ring Results

By Mario Admin | May 27, 2016

Phase II results of ForSight Vision5’s bimatoprost ocular ring insert have shown the ring achieves clinically significant reductions in intraocular pressure (IOP) over six months…

Read More

Diagnostics Here to Stay

By Mario Admin | May 26, 2016

A panel of physicians and corporate leaders discuss the increasingly important impact diagnostics have on the premium channel. Topics included number of tests done, appetite…

Read More

Diagnostics on the Rise

By Mario Admin | May 26, 2016

Richard Lindstrom, MD, opened up the Diagnostics-Impact on the Premium Channel with an overview of the market including a look at competitors. Video Highlights 00:37…

Read More

CZM Focuses on “A Lot of Little Things” to Move Premium Channel

By Mario Admin | May 25, 2016

Moving cataract surgery outcomes from 80% of patients within 0.5 D of targeted refraction to 95% requires “a lot of little things,” Karlheinz Rein, PhD,…

Read More

Aerie Looks for Rhopressa NDA in Q3

By Mario Admin | May 25, 2016

Aerie Pharmaceuticals has completed all patient visits in two Phase III clinical trials of the Rho kinase inhibitor Rhopressa (netarsudil) 0.02% for treatment of glaucoma…

Read More

Alcon’s Suite Approach to Building the Premium Channel

By Mario Admin | May 25, 2016

As cataract patients’ expectations rise, demanding visual performance on par with refractive surgery, Alcon is striving to meet those high expectations through its Cataract Refractive…

Read More

Physicians Say MIGs Is Transforming Glaucoma Treatment

By Mario Admin | May 25, 2016

Ike K. Ahmed, MD, led a discussion between three notable ophthalmologists treating glaucoma patients with MIGs. The panel followed a presentation by Ahmed and four…

Read More

LacriScience Enters Next Chapter

By Mario Admin | May 24, 2016

Chris D. Geddes, Ph.D, and Paul Gavaris of LacriScience share the prototype of the LacriPen, a handheld, portable, diagnostic tool that measures osmolarity to within…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.